Meritage Portfolio Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,547
| Closed | -$1.08M | – | 336 |
|
2025
Q1 | $1.08M | Buy |
3,547
+336
| +10% | +$102K | 0.07% | 185 |
|
2024
Q4 | $1.07M | Buy |
3,211
+142
| +5% | +$47.2K | 0.07% | 191 |
|
2024
Q3 | $1.02M | Buy |
3,069
+306
| +11% | +$102K | 0.06% | 199 |
|
2024
Q2 | $1.14M | Buy |
2,763
+30
| +1% | +$12.4K | 0.07% | 191 |
|
2024
Q1 | $1.11M | Sell |
2,733
-253
| -8% | -$102K | 0.07% | 196 |
|
2023
Q4 | $915K | Buy |
2,986
+158
| +6% | +$48.4K | 0.06% | 202 |
|
2023
Q3 | $685K | Buy |
2,828
+146
| +5% | +$35.4K | 0.05% | 215 |
|
2023
Q2 | $644K | Buy |
2,682
+799
| +42% | +$192K | 0.05% | 222 |
|
2023
Q1 | $354K | Buy |
1,883
+80
| +4% | +$15K | 0.03% | 231 |
|
2022
Q4 | $383K | Buy |
1,803
+46
| +3% | +$9.77K | 0.03% | 234 |
|
2022
Q3 | $276K | Buy |
1,757
+143
| +9% | +$22.5K | 0.02% | 257 |
|
2022
Q2 | $242K | Sell |
1,614
-121
| -7% | -$18.1K | 0.02% | 271 |
|
2022
Q1 | $284K | Sell |
1,735
-69,803
| -98% | -$11.4M | 0.02% | 280 |
|
2021
Q4 | $15.6M | Sell |
71,538
-459
| -0.6% | -$99.9K | 0.88% | 25 |
|
2021
Q3 | $13.6M | Buy |
71,997
+442
| +0.6% | +$83.7K | 0.82% | 27 |
|
2021
Q2 | $12.6M | Sell |
71,555
-705
| -1% | -$125K | 0.76% | 28 |
|
2021
Q1 | $11.9M | Sell |
72,260
-1,922
| -3% | -$315K | 0.79% | 27 |
|
2020
Q4 | $10.3M | Buy |
74,182
+1,017
| +1% | +$142K | 0.76% | 33 |
|
2020
Q3 | $8.18M | Sell |
73,165
-99
| -0.1% | -$11.1K | 0.73% | 34 |
|
2020
Q2 | $6.82M | Buy |
73,264
+2,947
| +4% | +$274K | 0.66% | 37 |
|
2020
Q1 | $5.16M | Buy |
+70,317
| New | +$5.16M | 0.7% | 36 |
|